» Articles » PMID: 38237103

Patient Acceptability of Telehealth Medication Abortion Care in the United States, 2021‒2022: A Cohort Study

Overview
Specialty Public Health
Date 2024 Jan 18
PMID 38237103
Authors
Affiliations
Soon will be listed here.
Abstract

Despite the recent expansion of direct-to-patient telehealth abortion care in the United States, patient experiences with the service are not well understood. We described care experiences of 1600 telehealth abortion patients in 2021 to 2022 and used logistic regression to explore differences by race or ethnicity and between synchronous (phone or video) and asynchronous (secure messaging) telehealth abortion care. Most patients trusted the provider (98%), felt telehealth was the right decision (96%), felt cared for (92%), and were very satisfied (89%). Patients most commonly cited privacy (76%), timeliness (74%), and staying at home (71%) as benefits. The most commonly reported drawback was initial uncertainty about whether the service was legitimate (38%). Asian patients were less likely to be very satisfied than White patients (79% vs 90%;  = .008). Acceptability was high for both synchronous and asynchronous care. Telehealth abortion care is highly acceptable, and benefits include privacy and expediency. Telehealth abortion can expand abortion access in an increasingly restricted landscape while maintaining patient-centered care. ( 2024;114(2):241-250. https://doi.org/10.2105/AJPH.2023.307437).

Citing Articles

Perceptions and experiences with two no-test direct-to-patient telehealth medication abortion regimens in the USA: an exploratory study with mifepristone and misoprostol and misoprostol-only regimens.

Johnson D, Thompson T, Fix L, Jastaniah I, Grant M BMJ Public Health. 2025; 2(2):e000808.

PMID: 40018617 PMC: 11816198. DOI: 10.1136/bmjph-2023-000808.


"Trust Women": Characteristics of and learnings from patients of a Shield Law medication abortion practice in the United States.

Foster A, Mark A, Drouillard K, Paul M, Yanow S, Shahi S Perspect Sex Reprod Health. 2024; 56(3):295-302.

PMID: 39350517 PMC: 11605996. DOI: 10.1111/psrh.12287.


Virtual Clinic Telehealth Abortion Services in the United States One Year After Dobbs: Landscape Review.

Koenig L, Ko J, Upadhyay U J Med Internet Res. 2024; 26:e50749.

PMID: 39102679 PMC: 11333862. DOI: 10.2196/50749.


Telehealth enables safe medication abortion in shifting health and legal contexts.

Johnson D, Aiken A, Thompson T Nat Med. 2024; 30(4):946-947.

PMID: 38491153 DOI: 10.1038/s41591-024-02876-0.


The Role of Telehealth in Promoting Equitable Abortion Access in the United States: Spatial Analysis.

Koenig L, Becker A, Ko J, Upadhyay U JMIR Public Health Surveill. 2023; 9:e45671.

PMID: 37934583 PMC: 10664017. DOI: 10.2196/45671.

References
1.
Aiken A, Starling J, van der Wal A, van der Vliet S, Broussard K, Johnson D . Demand for Self-Managed Medication Abortion Through an Online Telemedicine Service in the United States. Am J Public Health. 2019; 110(1):90-97. PMC: 6893344. DOI: 10.2105/AJPH.2019.305369. View

2.
Godfrey E, Thayer E, Fiastro A, Aiken A, Gomperts R . Family medicine provision of online medication abortion in three US states during COVID-19. Contraception. 2021; 104(1):54-60. PMC: 8086374. DOI: 10.1016/j.contraception.2021.04.026. View

3.
Aiken A, Upadhyay U . The future of medication abortion in a post-Roe world. BMJ. 2022; 377:o1393. DOI: 10.1136/bmj.o1393. View

4.
Allsworth J . Telemedicine, Medication Abortion, and Access After . Am J Public Health. 2022; 112(8):1086-1088. PMC: 9342806. DOI: 10.2105/AJPH.2022.306948. View

5.
Grossman D, Grindlay K, Buchacker T, Potter J, Schmertmann C . Changes in service delivery patterns after introduction of telemedicine provision of medical abortion in Iowa. Am J Public Health. 2012; 103(1):73-8. PMC: 3518368. DOI: 10.2105/AJPH.2012.301097. View